Close Menu

The Wall Street Journal has an article focusing on Andrew von Eschenbach, commissioner of the US Food and Drug Administration. Critics have charged that the FDA can't manage regulations of everything it's supposed to be regulating, and now von Eschenbach responds that "the agency needs more money than the Bush administration has proposed, and it requires a revamped organization to better oversee drug safety and other issues," according to the article.

 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new report offers ways for small, society publishers to transition to Plan S standards, ScienceInsider says.

A gas explosion sparked a fire at a Russian laboratory that stores dangerous pathogens, the Guardian reports.

Researchers turn to protein analysis to examine an ancient rhino sample, Smithsonian.com reports.

In PNAS this week: C2CD4A gene involved in insulin secretion, chromosome rearrangements in recurring S. aureus infections, and more.